120 related articles for article (PubMed ID: 12951413)
1. Erythrocyte-replaced mouse model for Haemoparasite studies: comparison of NOD/shi-scid and C.B-17/Jcl-scid mouse upon acceptability of human erythrocytes.
Ishihara C; Zamoto A; Tsuji M; Wei Q; Azuma I; Hioki K
J Vet Med Sci; 2003 Aug; 65(8):831-7. PubMed ID: 12951413
[TBL] [Abstract][Full Text] [Related]
2. Transfusion with xenogeneic erythrocytes into SCID mice and their clearance from the circulation.
Ishihara C; Tsuji M; Hagiwara K; Hioki K; Arikawa J; Azuma I
J Vet Med Sci; 1994 Dec; 56(6):1149-54. PubMed ID: 7696408
[TBL] [Abstract][Full Text] [Related]
3. Mannan decelerates the clearance of human red blood cells in SCID mouse.
Ishihara C; Hiratai R; Tsuji M; Yagi K; Nose M; Azuma I
Immunopharmacology; 1998 Jan; 38(3):223-8. PubMed ID: 9506821
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a SCID mouse model having circulating human red blood cells and a possible growth of Plasmodium falciparum in the mouse.
Tsuji M; Ishihara C; Arai S; Hiratai R; Azuma I
Vaccine; 1995; 13(15):1389-92. PubMed ID: 8578814
[TBL] [Abstract][Full Text] [Related]
5. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
[TBL] [Abstract][Full Text] [Related]
6. A sulfated chitin, SCM-chitin III, inhibits the clearance of human erythrocytes from the blood circulation in erythrocyte-transfused SCID mice.
Ishihara C; Shimakawa S; Tsuji M; Arikawa J; Tokura S
Immunopharmacology; 1995 Feb; 29(1):65-71. PubMed ID: 7768673
[TBL] [Abstract][Full Text] [Related]
7. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection.
Koyanagi Y; Tanaka Y; Tanaka R; Misawa N; Kawano Y; Tanaka T; Miyasaka M; Ito M; Ueyama Y; Yamamoto N
Leukemia; 1997 Apr; 11 Suppl 3():109-12. PubMed ID: 9209314
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice.
Saito-Ito A; Tsuji M; Wei Q; He S; Matsui T; Kohsaki M; Arai S; Kamiyama T; Hioki K; Ishihara C
J Clin Microbiol; 2000 Dec; 38(12):4511-6. PubMed ID: 11101588
[TBL] [Abstract][Full Text] [Related]
9. A method for rapid and complete substitution of the circulating erythrocytes in SCID mice with bovine erythrocytes and use of the substituted mice for bovine hemoprotozoa infections.
Nakamura Y; Tsuji M; Arai S; Ishihara C
J Immunol Methods; 1995 Dec; 188(2):247-54. PubMed ID: 8551053
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of TCR Vbeta subfamily T cell expansion in NOD/SCID mice transplanted with human cord blood hematopoietic stem cells.
Lin C; Chen S; Yang L; Tan Y; Bai X; Li Y
Hematology; 2007 Aug; 12(4):325-30. PubMed ID: 17654060
[TBL] [Abstract][Full Text] [Related]
12. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
Eguchi H; Kuroiwa Y; Matsui A; Sada M; Nagaya N; Kawano S
Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132
[TBL] [Abstract][Full Text] [Related]
13. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
[TBL] [Abstract][Full Text] [Related]
14. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
[TBL] [Abstract][Full Text] [Related]
15. Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma: a potential in vivo culture system.
Huang SY; Tien HF; Su FH; Hsu SM
Am J Pathol; 2004 Feb; 164(2):747-56. PubMed ID: 14742278
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
17. SCID mouse models of human stem cell engraftment.
Greiner DL; Hesselton RA; Shultz LD
Stem Cells; 1998; 16(3):166-77. PubMed ID: 9617892
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
Gao L; Wang JM; Xie LN; Zhou H; Qiu HY
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307
[TBL] [Abstract][Full Text] [Related]
19. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
20. Candida guilliermondii infection in SCID mice in association with the acceleration of the elimination of transfused human red blood cells.
Ishihara C; Miyamoto A; Kim SJ; Arai S; Taniyama H; Maejima K; Tsuji M
Exp Anim; 1998 Jan; 47(1):69-73. PubMed ID: 9498116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
